These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 22333280)

  • 41. Retrospective analysis of 17 liveborn neonates with hydrops fetalis.
    Liu CA; Huang HC; Chou YY
    Chang Gung Med J; 2002 Dec; 25(12):826-31. PubMed ID: 12635839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics and outcomes of fetuses with pericardial effusions.
    Slesnick TC; Ayres NA; Altman CA; Bezold LI; Eidem BW; Fraley JK; Kung GC; McMahon CJ; Pignatelli RH; Kovalchin JP
    Am J Cardiol; 2005 Aug; 96(4):599-601. PubMed ID: 16098320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thoracoamniotic shunting for fetal pleural effusions with hydrops.
    Picone O; Benachi A; Mandelbrot L; Ruano R; Dumez Y; Dommergues M
    Am J Obstet Gynecol; 2004 Dec; 191(6):2047-50. PubMed ID: 15592290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. De novo reciprocal translocation t(5;11)(q22;p15) associated with hydrops fetalis (reciprocal translocation and hydrops fetalis).
    Pala HG; Artunc-Ulkumen B; Uyar Y; Bal F; Baytur YB; Koyuncu FM
    Fetal Pediatr Pathol; 2015 Feb; 34(1):44-8. PubMed ID: 25289481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Non-immunologic fetal ascites and anasarca. Apropos of 44 cases].
    Mignon-Rigot I; Rudigoz RC; Salle B; Dargent D
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(8):1063-8. PubMed ID: 3069895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nonimmunologic hydrops fetalis--a review of 31 cases].
    Schmid G; Fahnenstich H; Redel D; Gembruch U; Niesen M; Kowalewski S
    Klin Padiatr; 1988; 200(4):287-93. PubMed ID: 3172669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antenatal presentation of hereditary lymphedema type I.
    Boudon E; Levy Y; Abossolo T; Cartault F; Brouillard P; Vikkula M; Kieffer-Traversier M; Ramful D; Alessandri JL
    Eur J Med Genet; 2015; 58(6-7):329-31. PubMed ID: 25896638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-immune hydrops fetalis in the first trimester: a review of 30 cases.
    Has R
    Clin Exp Obstet Gynecol; 2001; 28(3):187-90. PubMed ID: 11530871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Etiology and outcome of second trimester non-immunologic fetal hydrops.
    Heinonen S; Ryynänen M; Kirkinen P
    Acta Obstet Gynecol Scand; 2000 Jan; 79(1):15-8. PubMed ID: 10646810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome of fetal cystic hygroma and experience of intrauterine treatment.
    Ogita K; Suita S; Taguchi T; Yamanouchi T; Masumoto K; Tsukimori K; Nakano H
    Fetal Diagn Ther; 2001; 16(2):105-10. PubMed ID: 11173958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment.
    Sohan K; Carroll SG; De La Fuente S; Soothill P; Kyle P
    Acta Obstet Gynecol Scand; 2001 Aug; 80(8):726-30. PubMed ID: 11531615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α-thalassemia-associated hydrops fetalis: A rare cause of thyrotoxic cardiomyopathy.
    Tumian NR; Wong M; Wong CL
    J Obstet Gynaecol Res; 2015 Jun; 41(6):967-70. PubMed ID: 25510540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Nonimmune hydrops fetalis: two decades of experience in a university hospital].
    Fritsch A; Müller AL; Sanseverino MT; Kessler RG; Barrios PM; Patusco LM; Magalhães JA
    Rev Bras Ginecol Obstet; 2012 Jul; 34(7):310-5. PubMed ID: 22948503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis.
    ; Norton ME; Chauhan SP; Dashe JS
    Am J Obstet Gynecol; 2015 Feb; 212(2):127-39. PubMed ID: 25557883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complete spontaneous resolution of severe nonimmunological hydrops fetalis with unknown etiology in the second trimester--a case report.
    Henrich W; Heeger J; Schmider A; Dudenhausen JW
    J Perinat Med; 2002; 30(6):522-7. PubMed ID: 12530111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcome of nonimmune hydrops fetalis diagnosed during the first half of pregnancy.
    Iskaros J; Jauniaux E; Rodeck C
    Obstet Gynecol; 1997 Sep; 90(3):321-5. PubMed ID: 9277637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fetal cardiac troponin T as a marker of poor prognosis in nonimmune hydrops fetalis.
    Nomura RM; Brizot Mde L; Liao AW; Andrade JQ; Zugaib M
    Fetal Diagn Ther; 2009; 26(1):57-60. PubMed ID: 19816034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome and Treatment of Antenatally Diagnosed Nonimmune Hydrops Fetalis.
    Nassr AA; Ness A; Hosseinzadeh P; Salmanian B; Espinoza J; Berger V; Werner E; Erfani H; Welty S; Bateni ZH; Shamshirsaz AA; Popek E; Ruano R; Davis AS; Lee TC; Keswani S; Cass DL; Olutoye OO; Belfort MA; Shamshirsaz AA
    Fetal Diagn Ther; 2018; 43(2):123-128. PubMed ID: 28647738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonimmune hydrops fetalis: fetal and neonatal outcome during 1983-1992.
    Wafelman LS; Pollock BH; Kreutzer J; Richards DS; Hutchison AA
    Biol Neonate; 1999; 75(2):73-81. PubMed ID: 9852356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis.
    Fukushima K; Morokuma S; Fujita Y; Tsukimori K; Satoh S; Ochiai M; Hara T; Taguchi T; Wake N
    Early Hum Dev; 2011 Aug; 87(8):571-5. PubMed ID: 21592689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.